Persistent Asset Partners »

Adaptive Biotechnologies Cor shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $109k 6.7k 16.24

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Westfield Capital Management Company
Geode Capital Management
State Street Corporation
Invesco
Lord, Abbett & Co
Driehaus Capital Management
Goldman Sachs Group
Jennison Associates
Ameriprise Financial
Fred Alger Management
Arrowstreet Capital, Limited Partnership
ARK Investment Management

View all funds holding Adaptive Biotechnologies Cor